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Breast cancer
3D versus IMRT in left breast radiotherapy. Heart dose constraints
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Introduction. Left breast irradiation in patients with early breast cancer involves radiation-induced cardiovascular disease risk.
New dosimetric constraints, along with new RT regimens, technologies and target deﬁnition, are contributed to reducing heart
dose. Dose constraints associated with a <1% probability of cardiac mortality were deﬁned by Gaglilardi et al (V25Gy<10%) and
Pili et al (V30Gy<20 cm3, V40Gy<10 cm3, and V50Gy<2 cm3 for the dose constraints and D2cm3 <42Gy and D1cm3 <44Gy).
Recently mean dose below 5Gy was selected for late morbidity.
Purpose. To retrospectively evaluate heart dose parameters in patients with left breast cancer treated with adjuvant radiotherapy
in our department and to compare 3D versus IMRT techniques.
Methods. From May 2011 to Nov 2012, 200 breast cancer patients received adjuvant radiotherapy. 101 were left side. Postmas-
tectomy RT was performed in 38 patients and after breast conservative surgery in 63 patients. Treatment volumes were as
follow: breast alone: 4, breast and tumour bed (TB) 41, breast, TB and nodal 14, chest wall alone 6, chest wall and nodal
27. Dose and fractionation: 50Gy (2Gy/fracc): 40 pts; 45Gy+15Gy (seq boost) (1.8Gy/fracc): 5; 45Gy+15Gy (conc boost): 12;
40.05Gy (2.67Gy/fracc) + 10Gy (seq boost) (2Gy/fracc): 42. Treatment technique: 3D Tangential beams with compensating ﬁelds
(forward-IMRT): 96 pts; standard IMRT: 5 pts.
Results. 3D tangential with forward IMRT (96 pts) Mean dose: 3.47+1.66Gy. V25Gy: 3.8 + 2.8%. V30Gy: 19.2 + 16 cc. V40Gy:
10.6 + 12 cc. V50Gy: 0.6 + 1.7 cc. D2 cm3: 40.98+11.54Gy IMRT (5 pts) Mean dose: 11.9 + 3.63Gy. V25Gy: 7.8 + 4,3%. V30Gy: 31+21 cc.
V40Gy: 7.22+6.9 cc. V50Gy: 0.67+1.2 cc. D2 cm3: 41.53G+10Gy In both case; 95% PTV coverage was>95%
Conclusions. Modern heart dose constraints for adjuvant breast radiotherapy can achieve with 3D tangential with compensated
ﬁelds. Standard IMRT should be reserved for patients with excessive volume of lung (V20>30%) or heart (V25>10%) with 3D
treatment.
http://dx.doi.org/10.1016/j.rpor.2013.03.018
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Introduction. Randomized controlled trials comparing IMRT versus 3DRT have shown a signiﬁcant improvement in terms of
homogeneity and acute toxicity in favor of IMRT (Donovan E. Radiother Oncol 2007; Pignol JP. Clin Oncol 2008). However, the use
of tangential ﬁelds with reduced segments instead of a couple of tangencial beams with wedges could be a halfway technique
in between.
Methods. Between June 2010 and November 2012, patients with stage I–II low risk breast cancer who ﬁtted the inclusion criteria
of Whelan hypofractionated scheme were included in this analysis. Prescription dose was 43.2Gy in 16 fractions of 2.7Gy per
fraction. Planning treatment was based on paired tangential ﬁelds with the addition of reduced tangential ﬁelds used to increase
the dose homogeneity distribution throughout the breast volume. Treatment veriﬁcation was carried out with portal images in
all treatments.
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Results. A total of 135 women with a mean age of 67 years were analyzed. The average of ﬁelds used was 4.5 (range 3–8). The
mean breast volume that received ≥95% of the prescription dose was 97.6% and 0.5% was the average of volume that received
≥107% of the prescription dose. The mean maximum dose to the breast was 46.4Gy and the mean V20 in the ipsilateral lung
was 12.4%.
Conclusion. The use of tangential ﬁelds with reduced segments is a feasible treatment that allows acceptable dosimetric outcomes
in the setting of patients with low risk breast cancer who receive hypofractionated radiotherapy. Further studies that compare
multiple ﬁelds versus IMRT are needed to know if both techniques are equiparable.
http://dx.doi.org/10.1016/j.rpor.2013.03.071
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Backgruond. Three-dimensional conformal radiotherapy (3D-CRT) in the planning treatment of locorregional breast cancer includ-
ing the internal mammary chain is realized in our centre, by using tangential ﬁelds with multisegments; and PA-AP ﬁelds for
nodal areas. Helical Tomotherapy (HT) is a sort of intensity-modulated radiation therapy, that uses an integrated CT scanner
during radiation which is performed helicoidally.
Purpose. To compare the dosimetric distribution of two breast radiotherapy plans: Three-dimensional conformal radiotherapy vs
Helical Tomotherapy.
Methods and materials. Six patients with stage IIIC breast cancer affecting internal mammary chain (clinically and/or histologically
conﬁrmed), were included in this study. For each patient, treatment plans were generated to compare de Three-dimensional con-
formal radiotherapy (3D-CRT) against the Helical Tomotherapy (HT). CT simulation was performed in supine position with both
arms above head and external rotation. The planning target volumes (PTV) included the chest wall/whole breast, supraclavicular,
axillary, and internal mammary chain nodes. Dose prescription was 50.4Gy, in 28 fractions of 1.8Gy, to the PTV.
Results. The average V20 and V5 for heart was 7.28% and 84.94% for HT vs 2.73% and 8.18% for 3D-CRT. The average V30, V20 and
V5 for ipsilateral lung was 19.66%, 31.47% and 92.61% for HT vs 33.78%, 38.41% and 54.82% for 3D-CRT. The average percentage
of the contralateral lung receiving ≥5Gy was 62.41% for HT and 2.86% for 3D-CRT. The average percentage of the contralateral
breast receiving ≥5Gy was 50.33% for HT and 8.18% for 3D-CRT.
Conclusion. Tomotherapy decreases high dose irradiation in lung at the expense of a greater volume of lung and heart receiving
low-dose irradiation and higher irradiation of contralateral breast and lung. The choice of treatment plan must be individualized
for each patient based on doses in heart, and contralateral breast and lung.
http://dx.doi.org/10.1016/j.rpor.2013.03.072
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Introduction. New accelerated hypofractionated treatments for breast irradiation are an important improvement of the conven-
tional treatment schemes that allow an early return of the patients to them previous lifestyle. The tolerance, cosmetic results,
local control and survival of these new treatments must be the same, or better, as that of conventional treatments. Objective:
Implementation of accelerated hypofractionation 40Gy in 15 sessions for mammary gland irradiation.
Material and methods. Since 2011, 50 patients have been treated with this hypofractionation schema in our institution. All patients
presented lesions smaller than 1 cm treated with conservative surgery. Exclusive mammary gland irradiation was performed
using IMRT to improve dose homogeneity. We have developed protocols to provide speciﬁc requirements in the deﬁnition of
structures, dosimetric acceptance criteria, positioning control, which includes changes in the breast volume, and speciﬁc care
treatment for toxicities prevention. Tracking of skin toxicitywas doneusing visual rating scales for its quantitative determination.
To assess the quality of life of patients we used surveys DLQI and Skindex-29.
Results. Uncertainty in the patient setup was less than 3mm. The average dose of breast PTV is greater than 98%, maximum
dose is less than 106% and D95 is greater than 95%. V20 of lung is smaller than 15%, and less than 3% for heart. Only dermatitis
grade I was detected as dermal toxicity in some patients. The DLQI surveys conducted to evaluate changes in the quality of life of
patients showed very low condition being the items on pain, burning and itching the highest. Skindex-29 showed an involvement
low or very low.
